Cogent Biosciences Inc (NASDAQ: COGT) Has Dropped -13.97% Year-To-Date (YTD): Any Trouble Coming?

NOVA

Cogent Biosciences Inc (NASDAQ:COGT)’s traded shares stood at 1.6 million during the last session, with the company’s beta value hitting 1.82. At the close of trading, the stock’s price was $6.71, to imply a decrease of -4.01% or -$0.28 in intraday trading. The COGT share’s 52-week high remains $12.61, putting it -87.93% down since that peak but still an impressive 14.61% since price per share fell to its 52-week low of $5.73.

Analysts have given a consensus recommendation of Buy for Cogent Biosciences Inc (COGT), translating to a mean rating of 1.55. Of 4 analyst(s) looking at the stock, 0 analyst(s) give COGT a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 4 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at -0.63.

Cogent Biosciences Inc (NASDAQ:COGT) trade information

After registering a -4.01% downside in the last session, Cogent Biosciences Inc (COGT) has traded red over the past five days. The 5-day price performance for the stock is -16.96%, and -20.78% over 30 days. With these gigs, the year-to-date price performance is -13.97%.

The extremes give us $14 and $15 for target low and target high price respectively. As such, COGT has been trading -123.55% off suggested target high and -108.64% from its likely low.

Cogent Biosciences Inc (COGT) estimates and forecasts

An assessment of the company’s 5-year growth patterns shows that annual earnings grew an estimated 10.02% for the past 5-year period. While 2025 is set for a -0.25% return in earnings, projections for the next 5 years are at 10.59% annually.

COGT Dividends

Cogent Biosciences Inc has its next earnings report out in March. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.

Cogent Biosciences Inc (NASDAQ:COGT)’s Major holders

The next major institution holding the largest number of shares is COMMODORE CAPITAL LP with 9.74 million shares, or about 9.8126% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $82.09 million.